| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |